Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomatitis 1 Mucositis 1

Interventions

Cyclophosphamide 910 Carboplatin 787 pembrolizumab 746 Paclitaxel 743 Cisplatin 709 Bevacizumab 707 Gemcitabine 619 Docetaxel 580 Rituximab 549 Radiotherapy 541 Dexamethasone 512 Nivolumab 489 Doxorubicin 445 Fluorouracil 392 Capecitabine 376 Etoposide 358 Pemetrexed 337 Cytarabine 335 Oxaliplatin 333 Lenalidomide 328 Prednisone 327 fludarabine phosphate 316 Erlotinib Hydrochloride 314 Trastuzumab 300 Leucovorin 299 fludarabine 296 Vincristine 287 Filgrastim 284 Bortezomib 284 Cetuximab 276

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Has results × Poloxamer × Clear all

NCT01898091 2017-03-06

OM

Medical University of South Carolina

Phase 2 Completed

50 enrolled 9 charts

Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡